Streetbeat News

Stock Prices

PHVS

Over the past 3 months, 8 analysts have published their opinion on Pharvaris (NASDAQ:PHVS) stock. The company has an average price target of $13.0 with a high of $34.00 and a low of $10.00. The average price target has increased by 30.0% over the past month. Most analysts are indifferent about the stock.

Portfolio Pulse from Benzinga Insights

August 15, 2023 | 12:00 pm

GLTO

The trading of Galecto's shares has resumed.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2023 | 12:00 pm

HALO

In the last quarter, Halozyme Therapeutics (NASDAQ:HALO) received 2 bullish, 1 somewhat bullish, and 1 indifferent rating from analysts. The company's average 12-month price target is $56.75, which has increased by 3.8% over the past month.

Portfolio Pulse from Benzinga Insights

August 15, 2023 | 12:00 pm

AMZN

David Limp, the head of Amazon's device division, plans to leave the company after 13 years. His departure is the latest in a series of high-profile exits since Andy Jassy took over as CEO. Limp's division, which includes Amazon's Alexa and other services and gadgets, has struggled to generate profits. The division was also affected by Jassy's cost-cutting measures, which resulted in the loss of 27,000 jobs. Despite selling over 500 million Alexa-enabled devices, the unit has reported operating losses exceeding $5 billion in some years.

Portfolio Pulse from Anusuya Lahiri

August 15, 2023 | 11:56 am

GLTO

Trading of Galecto, Inc. Common Stock shares is set to resume at 8:00 a.m. ET.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2023 | 11:48 am

RCL

SGTX

SRPT

Insider trades were noted in three healthcare stocks: Royal Caribbean Cruises Ltd. (RCL), Sarepta Therapeutics, Inc. (SRPT), and Sigilon Therapeutics, Inc. (SGTX). RCL's director acquired 1,000 shares, indicating confidence in the company's prospects after reporting Q2 sales growth. SRPT's director acquired 23,686 shares following a narrower-than-expected Q2 loss. Shenandoah Acquisition Corp, a 10% owner of SGTX, bought 1,718,493 shares after Eli Lilly agreed to acquire the company.

Portfolio Pulse from Lisa Levin

August 15, 2023 | 11:44 am

FRHC

Freedom Holding Corp's shares fell by 7.5% following a short report from Hindenburg Research. The report likely contains negative information about the company, leading to the drop in share price.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2023 | 11:40 am

ZYNE

HC Wainwright & Co. analyst Corey Davis has downgraded Zynerba Pharmaceuticals from Buy to Neutral.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2023 | 11:37 am

HD

QQQ

SPY

US stock futures faltered on Tuesday due to China's unexpected rate cut and Home Depot's disappointing Q2 earnings report. Analysts from LPL suggest a 5-10% pullback in stocks is overdue. In premarket trading, the SPDR S&P 500 ETF Trust (SPY) and the Invesco QQQ ETF (QQQ) both retreated. Home Depot, Discover Financial Services, Cardinal Health, Tencent Music Entertainment Group, Agilent Technologies, Jack Henry & Associates, and H&R Block are all mentioned in relation to earnings reports or leadership changes.

Portfolio Pulse from Shanthi Rexaline

August 15, 2023 | 11:36 am

ONON

On Holding AG reported Q2 FY23 results, with sales growth of 52.3% Y/Y to CHF 444.3 million. The company's adjusted EPS was CHF 0.04, lower than CHF 0.14 last year. In USD terms, the Q2 adjusted EPS of $0.04 missed the consensus of $0.13, while sales of $494.08 million beat the consensus of $463.07 million. The company raised its FY23 sales guidance, expecting revenues to reach at least CHF 1.76 billion. Despite the positive results, ONON shares are trading lower by around 7%.

Portfolio Pulse from Lekha Gupta

August 15, 2023 | 11:35 am